ESHO
European Society of Hyperthermic
Oncology
Studies on Hodgkin`s- and Non-Hodgkin`s-Lymphoma
Whole body hyperthermia:
Clinical phase II study of combined thermo-chemotherapy (whole body hyperthermia plus Melphalan, Ifosfamide, Carboplatin and Etoposide) in primary refractory or recurrent Hodgkin’s and Non-Hodgkin’s-Lymphomas.
Coordination:
Prof. Dr. med. S. Hegewisch-Becker
Abt. für Onkologie und Hämatologie
Universitätskrankenhaus Eppendorf
Hamburg
Tel: +49-40-42803-3971